Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
1.600
+0.005 (0.31%)
Nov 11, 2026, 11:57 AM EST - Market open
BDTX Market Cap
BDTX has a market cap or net worth of $91.95 million as of November 11, 2026. It is the 25,567th most valuable company in the world and the 4,128th biggest in the United States. Its market cap has decreased by 62.98% in one year.
Market Cap
91.95M
Enterprise Value
5.96M
1-Year Change
-62.98%
Global Rank
Country Rank
#4,128 United States
Category
ChartMarket Cap Chart
Since January 30, 2020, BDTX's market cap has decreased from $1.36B to $91.95M, a decrease of -93.21%. That is a compound annual growth rate of -32.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 91.95M | -33.59% |
| Dec 31, 2025 | 138.45M | 14.33% |
| Dec 31, 2024 | 121.09M | -16.54% |
| Dec 29, 2023 | 145.09M | 121.66% |
| Dec 30, 2022 | 65.46M | -66.10% |
| Dec 31, 2021 | 193.10M | -83.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Outlook Therapeutics | 111.82M |
| Anixa Biosciences | 109.85M |
| Immunic | 108.61M |
| TuHURA Biosciences | 105.79M |
| NovaBridge Biosciences | 105.42M |
| Milestone Pharmaceuticals | 103.99M |
| Retension Pharmaceuticals | 103.23M |
| Unicycive Therapeutics | 103.06M |